Endo International Ordinary Shares reported $2.2B in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Aerie Pharmaceuticals AERI:US $ 311.41M 5.56M
Amarin AMRN:US $ 719.12M 53.5M
Ani Pharmaceuticals ANIP:US $ 322.4M 21M
Bristol Myers Squibb BMY:US $ 30186M 65M
Coherus Biosciences CHRS:US $ 446.78M 65.66M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Endo International Ordinary Shares ENDP:US $ 2199.9M 292.89M
Heron Therapeutics HRTX:US $ 194.21M 28.38M
Hikma Pharmaceutical HIK:LN 176.1B 21.32B
Horizon Pharma HZNP:US $ 3203.09M 255.36M
JAZZ PHA JAZZ:US $ 2590.83M 89.98M
Lannett LCI:US $ 290.12M 28.59M
Ligand Pharmaceuticals LGND:US $ 243.78M 32.28M
Novartis NOVN:VX 38.14B 906M
Pacira Pharmaceuticals PCRX:US $ 526.21M 140.81M
Patterson Companies PDCO:US $ 1705.98M 26.96M
Perrigo Ordinary Shares PRGO:US $ 2651.5M 1284M
Phibro Animal Health PAHC:US $ 566.23M 19.76M
Revance Therapeutics RVNC:US $ 260.94M 24.38M
Supernus Pharmaceuticals SUPN:US $ 625.12M 56.6M
Takeda 4502:JP Y 2549515M 44127M
Teva Pharmaceutical TEVA:IT 12.16B 287M
Xeris Pharmaceuticals Inc XERS:US $ 161.21M 16.34M
Zoetis ZTS:US $ 6651M 186M